Abiomed Inc (ABMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 203,009 | 171,211 | 101,994 | 88,923 | 259,016 |
| Depreciation Amortization | 20,430 | 14,427 | 9,052 | 4,365 | 14,121 |
| Income taxes - deferred | 32,953 | 30,551 | 10,195 | 10,776 | -7,745 |
| Accounts receivable | 5,551 | -10,333 | -3,828 | 4,801 | -22,023 |
| Accounts payable and accrued liabilities | 2,581 | 841 | 781 | -1,463 | 7,976 |
| Other Working Capital | 8,025 | -30,460 | -17,613 | -14,194 | -38,841 |
| Other Operating Activity | 42,371 | 52,090 | 38,306 | -28,580 | 39,693 |
| Operating Cash Flow | $314,920 | $228,327 | $138,887 | $64,628 | $252,197 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -60,492 | -81,057 | -5,604 | -30,887 | -29,716 |
| PPE Investments | -44,006 | -33,460 | -24,607 | -12,250 | -44,004 |
| Purchase Of Investment | -20,957 | -20,899 | -7,800 | -2,800 | -42,735 |
| Investing Cash Flow | $-125,455 | $-135,416 | $-38,011 | $-45,937 | $-116,455 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8,851 | 5,533 | 5,074 | 1,260 | 16,001 |
| Common Stock Repurchased | -84,879 | -59,876 | -34,873 | N/A | N/A |
| Other Financing Activity | -41,687 | -41,607 | -41,206 | -40,536 | -71,776 |
| Financing Cash Flow | $-117,715 | $-95,950 | $-71,005 | $-39,276 | $-55,775 |
| Exchange Rate Effect | -430 | -12 | -613 | 612 | -1,921 |
| Beginning Cash Position | 121,021 | 121,021 | 121,021 | 121,021 | 42,975 |
| End Cash Position | 192,341 | 117,970 | 150,279 | 101,048 | 121,021 |
| Net Cash Flow | $71,320 | $-3,051 | $29,258 | $-19,973 | $78,046 |
| Free Cash Flow | |||||
| Operating Cash Flow | 314,920 | 228,327 | 138,887 | 64,628 | 252,197 |
| Capital Expenditure | -44,006 | -33,460 | -24,607 | -12,250 | -44,004 |
| Free Cash Flow | 270,914 | 194,867 | 114,280 | 52,378 | 208,193 |